Célia F. Rodrigues

Célia F. Rodrigues




Qualificações

  • 2018: Programa Doutoral em Engenharia Química e Biológica, Universidade do Minho
  • 2004: Clinical and Public Health Analysis (BSc), Instituto Politécnico de Saúde do Norte
  • 2009: Pharmaceutical Sciences (BSc and MSc), Instituto Superior de Ciências da Saúde - Norte

  • 2018 - 2018: Candida biofilms: mechanisms of antifungal resistance. HPLC quantification of chlorhexidine and MGO in biological samples.
  • 2014 - 2018: Candida glabrata biofilms: mechanisms of antifungal resistance and matrix role
  • 2013 - 2014: Tolerance mechanisms of biofilms of Candida glabrata to antifungal drugs.


Publicações Recentes

1
Design of an antifungal surface embedding liposomal Amphotericin b through a mussel adhesive-inspired coating strategy
  • Frontiers in Chemistry, 7(431), 2019
2
Inflammatory cell recruitment in Candida glabrata biofilm cell-infected mice receiving antifungal chemotherapy
  • Journal of Clinical Medicine, 8(2), 2019
3
Candida sp. infections in patients with Diabetes mellitus
  • Journal of Clinical Medicine, 8(1), 2019
4
Promising alternative therapeutics for oral candidiasis
  • Current Medicinal Chemistry, 26(14), 2515-2528, 2019
5
Combination of Posaconazole and Amphotericin B in the Treatment of Candida glabrata Biofilms
  • Microorganisms, 6(4), 123, 2018
6
The MNN2 gene knockout modulates the antifungal resistance of biofilms of Candida glabrata
  • Biomolecules, 8(4), 130, 2018
7
Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition
  • BIOFOULING, 34(5), 569-578, 2018
8
Portrait of matrix gene expression in Candida glabrata biofilms with stress induced by different drugs
  • Genes, 9(4), 205, 2018
9
Synergistic antimicrobial interaction between honey and phage against Escherichia coli biofilms
  • Frontiers in Microbiology, 8(2407), 2017
10
Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.
  • Pathogens, 6(4), 62, 2017
11
The carboxylic acid transporters Jen1 and Jen2 affect the architecture and fluconazole susceptibility of Candida albicans biofilm in the presence of lactate
  • BIOFOULING, 33(10), 943-954, 2017
12
The effectiveness of voriconazole in therapy of Candida glabrata’s biofilms oral infections and its influence on the matrix composition and gene expression
  • MYCOPATHOLOGIA, 182(7-8), 653-664, 2017
13
Oral mucositis caused by Candida glabrata biofilms: failure of the concomitant use of fluconazole and ascorbic acid
  • Therapeutic Advances in Infectious Disease, 4(1), 10-17, 2017
14
Candida glabrata biofilms: How far have we come?
  • Journal of Fungi, 3(1), 11, 2017
15
Candida species biofilms' antifungal resistance
  • Journal of Fungi, 3(1, 8), 1-17, 2017
16
Candida glabrata's recurrent infections: biofilms formation during Amphotericin B treatment
  • Letters in Applied Microbiology, 63(2), 77-81, 2016
17
Detection and quantification of fluconazole within Candida glabrata biofilms
  • MYCOPATHOLOGIA, 179(5-6), 391-395, 2015
18
Candida glabrata: a review of its features and resistance
  • EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 33(5), 673-688, 2014
19
Effects of fluconazole on Candida glabrata biofilms and its relationship with ABC transporter gene expression
  • BIOFOULING, 30(4), 447-457, 2014
20
  • Rodrigues, Célia F.; Kelly Ascenção; Francisco Mendes Silva; Bruno Sarmento; Beatriz Oliveira; José Carlos Andrade
Drug delivery systems of green tea cathechins for improved stability and bioavailability
  • Current Medicinal Chemistry, 20(37), 4744-4757, 2013
Listagem Completa de Publicações





2019 © DEB - Departamento de Engenharia Biológica. Todos os Direitos Reservados.